ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
DocMcstuffins
|
181 |
71K |
0 |
05:14 |
05:14 |
ASX - By Stock
|
181
|
71K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
DocMcstuffins
|
449 |
138K |
7 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
DocMcstuffins
|
18K |
10M |
8 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
18K
|
10M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
DocMcstuffins
|
226 |
72K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
72K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
DocMcstuffins
|
11K |
5.9M |
20 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
11K
|
5.9M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
DocMcstuffins
|
17K |
6.5M |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
17K
|
6.5M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
DocMcstuffins
|
17K |
6.5M |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
17K
|
6.5M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Partnership deals......
|
|
DocMcstuffins
|
102 |
19K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
102
|
19K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Partnership deals......
|
|
DocMcstuffins
|
102 |
19K |
5 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
102
|
19K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
Short Activity in PNV
|
|
DocMcstuffins
|
6.7K |
2.0M |
2 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
6.7K
|
2.0M
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
DocMcstuffins
|
18K |
10M |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
18K
|
10M
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
DocMcstuffins
|
11K |
5.9M |
7 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
11K
|
5.9M
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
DocMcstuffins
|
18K |
10M |
4 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
18K
|
10M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
2 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
510
|
148K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
2 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
510
|
148K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
3 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
510
|
148K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
3 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
510
|
148K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
2 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
510
|
148K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
2 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
510
|
148K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
0 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
510
|
148K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
0 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
510
|
148K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
DocMcstuffins
|
154 |
43K |
0 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
154
|
43K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
DocMcstuffins
|
154 |
43K |
1 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
154
|
43K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
DocMcstuffins
|
154 |
43K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
154
|
43K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
DocMcstuffins
|
18K |
10M |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
18K
|
10M
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
DocMcstuffins
|
11K |
5.9M |
13 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
11K
|
5.9M
|
13
|
|
ASX - By Stock
|
PNV |
Re:
Short Activity in PNV
|
|
DocMcstuffins
|
6.7K |
2.0M |
4 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
6.7K
|
2.0M
|
4
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
DocMcstuffins
|
18K |
10M |
9 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
18K
|
10M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
510
|
148K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
510
|
148K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
510
|
148K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
DocMcstuffins
|
154 |
43K |
8 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
43K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
510
|
148K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
DocMcstuffins
|
510 |
148K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
510
|
148K
|
0
|
|